These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35927042)

  • 21. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory tract infections in cystic fibrosis.
    Weiner DJ
    Pediatr Ann; 2002 Feb; 31(2):116-23. PubMed ID: 11862722
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The difficulties of treating infection in adults with cystic fibrosis.
    Webb AK
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):657-61. PubMed ID: 8124307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial.
    Eklöf J; Alispahic IA; Sivapalan P; Wilcke T; Seersholm N; Armbruster K; Kjærgaard JL; Saeed MI; Nielsen TL; Browatzki A; Overgaard RH; Fenlev CS; Harboe ZB; Andreassen HF; Lapperre TS; Pedersen L; Johnsen S; Ulrik CS; Janner J; Moberg M; Heidemann M; Weinreich UM; Vijdea R; Linde H; Titlestad I; Johansson SL; Rosenvinge FS; Østergaard C; Ghathian KSA; Gundersen L; Christensen CW; Bangsborg J; Jensen TT; Sørensen VM; Ellingsgaard T; Datcu R; Coia JE; Bodtger U; Jensen JUS
    Trials; 2022 Sep; 23(1):817. PubMed ID: 36167555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
    Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
    Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.
    Robinson P; Carzino R; Armstrong D; Olinsky A
    J Clin Microbiol; 2003 Dec; 41(12):5741. PubMed ID: 14662972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1999 Sep; 28(3):159-66. PubMed ID: 10495331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
    Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
    Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational parameters for antibiotic therapy in patients with cystic fibrosis.
    Govan JR; Doherty C; Glass S
    Infection; 1987; 15(4):300-7. PubMed ID: 3117704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of severe lower respiratory infections in patients with cystic fibrosis.
    Speert DP
    Semin Respir Infect; 1989 Dec; 4(4):266-71. PubMed ID: 2516638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.